February 2003

From Scorpion to Cancer

April 25, 2008

MOTHER NATURE BUILT IT, MAN IS IMPROVING IT. TransMolecular’s 131 ITM601 is a synthetic version of a peptide from the venom of scorpions combined with a radioactive iodine. In Phase I/II trials to treat glioma,a deadly form of brain cancer, the product can deliver a targeted dose of radiation to cancerous cells without affecting normal […]

After 20 Years of DTC, It’s Time for a New Definition

April 25, 2008

54 F e b ru a r y 200 3 PharmaVOICE S THE NEW YEAR BEGINS TO UNFOLD, the pharmaceuti cal industry continues to face challenges on many fronts. Corpo rate profits are down, R&D pipelines have slowed, Washington politicians haven’t eased their attacks, and public perception is near an alltime low. With big pharma […]

Piecing Together the Privacy Puzzle

April 25, 2008

As healthcare providers PREPARE TO COMPLY with the PATIENT PRIVACY ISSUES stemming from the HEALTH INFORMATION PORTABILITY AND ACCOUNTABILITY ACT, the pharmaceutical industry will have to FIND WAYS TO WORK with business partners within the CONFINES OF THE LAW if they want to continue to gain access to data. Starting in April 2003 patients will […]

Net Returns — An Integrated Approach to Marketing

April 25, 2008

An Integrated Approach to Marketing FOLLOWING THE HYPE AND QUICK UPTAKE THAT MARKED THE INTERNET EXPLOSION OF THE LATE 1990S, MANY COMPANIES STEPPED BACK FROM THE MEDIUM. AS THE INTERNET CONTINUES TO MATURE AS A COMMUNICATIONS VEHICLE, THE HEALTHCARE INDUSTRY IS RETURNING TO THE WEB AND INTEGRATING ONLINE INITIATIVES AS PART OF THE MARKETING PLAN. […]

A Value Proposition: Managing the Supply Chain

April 25, 2008

*Solutions that encompass the strategy, processes, people, technologies, and resources responsible for ensuring the flow of materials and services are necessary to deliver an organization’s value to its end-user customers.* MANAGING INVENTORIES, WORKING CLOSELY WITH CONTRACTED SUPPLIERS TO ENSURE DELIVERIES, AND ENSURING THAT HEALTHCARE PROFESSIONALS HAVE PREFERRED MATERIALS ARE ALL CRUCIAL,BEHIND THE SCENES ELEMENTS TO A COMPANY’S […]

Talent Pool

April 24, 2008

Pharma POOL Dr. Peter KRUSE Tom MARTIN Dr. Brett E. SKOLNICK Novo Nordisk Expands Clinical Development Staff in U.S. BioPharmaceuticals Division, Promotes IT Staff Member Novo Nordisk has announced the appoint ment of Brett E. Skolnick, Ph.D., as director of clinical research, and Peter Kruse, M.D., Ph.D., as associate medical director in its U.S. BioPharmaceuticals […]

E-Media

April 24, 2008

84 F e b ru a r y 200 3 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ProscapeTechnologies has anew Internet tool to make facetoface selling more effective. Proscape.Net provides mobile sales organizations a common technolo gy platform to exchange, update, communicate, monitor, and present sales and marketing information during sales presentations. […]

What’s New

April 24, 2008

WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Pharmaceutical companies wanting to gain an edge in managedcare markets can turn to PharmaStrat Inc. for comprehensive market research services.The recently launched company was founded by Philip J. Patrick, a pharmaceutical executive with expertise in managedcare market dynamics,who is president. “Pharmaceutical marketing executives make sig nificant investments […]

On the Calendar

April 24, 2008

February 10,2003,Park Hyatt San Francisco — San Francisco European Regulatory Affairs: An InDepth Review of Registration Procedures in the European Union This Drug Information Association training course will cover the evolu tion of the registration systems available for approval of products since Jan uary 1995 in the European Union. Detailed review will be offered on […]

PharmaTrax

April 24, 2008

Survey Shows One Third of Americans USE ANTIBIOTICS INAPPROPRIATELY A survey conducted by Harris Interactive has revealed that one out of three Americans mistakenly believes antibiotics are effective in treating viruses such as cold and flu and takes these drugs to fight these viruses. The survey findings were released by the Council for Affordable Quality […]

For Art’s Sake

April 24, 2008

CREATIVE REVIEW One of my goals at RealAge is to show our members that to stay healthy and young, they have to actively engage in a wholebody approach. Another goal is to make sure our approach is meaty enough to get their attention and motivate them to take action. One of the ways we do this […]

PharmaOutlet

April 24, 2008

When launching a newproduct, marketers tend to focus on core audiences such as the physician and the patient, and on the clinical aspects of the drug, highlighting safety and clinical effectiveness. These factors are essential to a successful launch, but there are two additional fac tors that are rapidly growing in importance. The first is […]

What’s on Your Mind: Opinions

April 24, 2008

A bold, broad, unapologetic proclamation of benefits The most significant thing PhRMA and its constituent members can do is adopt a stronger, more assertive, and more proactive voice in the public debate over health and healthcare choices and expenditures. Past efforts to justify industry pricing and profits by repeatedly referencing the high cost of R&D […]

Letter from the Editor

April 24, 2008

PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Three, Number Two PharmaVOICE is published 12 times per year by PharmaLinx LLC, P.O.Box […]

FEEDBACK